The DOI matches its Crossref record; 186 of the 186 references it cites were found in a registry or an index.
Arachidonic Acid Metabolism and Kidney Inflammation
Open accessAbstract
As a major component of cell membrane lipids, Arachidonic acid (AA), being a major component of the cell membrane lipid content, is mainly metabolized by three kinds of enzymes: cyclooxygenase (COX), lipoxygenase (LOX), and cytochrome P450 (CYP450) enzymes. Based on these three metabolic pathways, AA could be converted into various metabolites that trigger different inflammatory responses. In the kidney, prostaglandins (PG), thromboxane (Tx), leukotrienes (LTs) and hydroxyeicosatetraenoic acids (HETEs) are the major metabolites generated from AA. An increased level of prostaglandins (PGs), TxA2 and leukotriene B4 (LTB4) results in inflammatory damage to the kidney. Moreover, the LTB4-leukotriene B4 receptor 1 (BLT1) axis participates in the acute kidney injury via mediating the recruitment of renal neutrophils. In addition, AA can regulate renal ion transport through 19-hydroxystilbenetetraenoic acid (19-HETE) and 20-HETE, both of which are produced by cytochrome P450 monooxygenase. Epoxyeicosatrienoic acids (EETs) generated by the CYP450 enzyme also plays a paramount role in the kidney damage during the inflammation process. For example, 14 and 15-EET mitigated ischemia/reperfusion-caused renal tubular epithelial cell damage. Many drug candidates that target the AA metabolism pathways are being developed to treat kidney inflammation. These observations support an extraordinary interest in a wide range of studies on drug interventions aiming to control AA metabolism and kidney inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2015) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,533
Origin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618
Bombardier, C., Laine, L., Reicin, A., Shapiro, D., Burgos-Vargas, R., Davis, B., Day, R., Ferraz, M. B., Hawkey, C. J., Hochberg, M. C., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011233432103 · Cited by 4,027
Cyclooxygenases: Structural, cellular, and molecular biology
Smith, W. L., DeWitt, D. L., & Garavito, R. M. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.145 · Cited by 2,925 · cited 1×
“Three things that need to be especially pointed out are that platelets mainly form TXA2, endothelial cells mainly form PGI2, and PGE2 is the main prostatic body produced by renal collecting tubule cells [34].”
BackgroundCyclooxygenase in biology and disease
DuBois, R. N., Abramson, S. B., Crofford, L., Gupta, R. A., Simon, L. S., van de Putte, L. B. A., & Lipsky, P. E. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.12.1063 · Cited by 2,506
Chandrasekharan, N. V., Dai, H., Roos, K. L. T., Evanson, N. K., Tomsik, J., Elton, T. S., & Simmons, D. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162468699 · Cited by 1,989
Prostaglandin Endoperoxide H Synthases (Cyclooxygenases)-1 and −2
Smith, W. L., Garavito, R. M., & DeWitt, D. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.52.33157 · Cited by 1,978
Non-Transgenic Mouse Models of Kidney Disease
Rabe, M., & Schaefer, F. (2016) · Nephron · doi:10.1159/000445171 · Cited by 1,922
Oxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPARγ
Nagy, L., Tontonoz, P., Alvarez, J. G. A., Chen, H., & Evans, R. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81574-3 · Cited by 1,860
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
Ostrand-Rosenberg, S., & Sinha, P. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802740 · Cited by 1,736
Marine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance
Calder, P. C. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.08.010 · Cited by 1,717
Clinical importance of the cytochromes P450
Nebert, D. W., & Russell, D. W. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11203-7 · Cited by 1,414
Di Rosa, M., Giroud, J. P., & Willoughby, D. A. (1971) · The Journal of Pathology · doi:10.1002/path.1711040103 · Cited by 1,402
P-450 Metabolites of Arachidonic Acid in the Control of Cardiovascular Function
Roman, R. J. (2002) · Physiological Reviews · doi:10.1152/physrev.00021.2001 · Cited by 1,309
Anti-inflammatory Properties of Cytochrome P450 Epoxygenase-Derived Eicosanoids
Node, K., Huo, Y., Ruan, X., Yang, B., Spiecker, M., Ley, K., Zeldin, D. C., & Liao, J. K. (1999) · Science · doi:10.1126/science.285.5431.1276 · Cited by 1,215
The Organization, Promoter Analysis, and Expression of the Human PPARγ Gene
Fajas, L., Auboeuf, D., Raspé, E., Schoonjans, K., Lefebvre, A.-M., Saladin, R., Najib, J., Laville, M., Fruchart, J.-C., Deeb, S., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.30.18779 · Cited by 1,188
Hawkey, C. (1999) · The Lancet · doi:10.1016/s0140-6736(98)12154-2 · Cited by 1,173
Hirai, H., Tanaka, K., Yoshie, O., Ogawa, K., Kenmotsu, K., Takamori, Y., Ichimasa, M., Sugamura, K., Nakamura, M., Takano, S., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.2.255 · Cited by 1,099
Prostanoid Receptors: Subtypes and Signaling
Breyer, R. M., Bagdassarian, C. K., Myers, S. A., & Breyer, M. D. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.661 · Cited by 1,011
Interleukin-4-dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase
Huang, J. T., Welch, J. S., Ricote, M., Binder, C. J., Willson, T. M., Kelly, C., Witztum, J. L., Funk, C. D., Conrad, D., & Glass, C. K. (1999) · Nature · doi:10.1038/22572 · Cited by 855
Shlipak, M. G., Fried, L. F., Cushman, M., Manolio, T. A., Peterson, D., Stehman-Breen, C., Bleyer, A., Newman, A., Siscovick, D., & Psaty, B. (2005) · JAMA · doi:10.1001/jama.293.14.1737 · Cited by 735
PPARs: therapeutic targets for metabolic disease
Berger, J. P., Akiyama, T. E., & Meinke, P. T. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.03.003 · Cited by 713
Ibuprofen: pharmacology, efficacy and safety
Rainsford, K. D. (2009) · Inflammopharmacology · doi:10.1007/s10787-009-0016-x · Cited by 667
Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases
Imig, J. D., & Hammock, B. D. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2875 · Cited by 614
Catella-Lawson, F., McAdam, B., Morrison, B. W., Kapoor, S., Kujubu, D., Antes, L., Lasseter, K. C., Quan, H., Gertz, B. J., & Fitzgerald, G. A. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38195-9 · Cited by 597
5-Lipoxygenase, a key enzyme for leukotriene biosynthesis in health and disease
Rådmark, O., Werz, O., Steinhilber, D., & Samuelsson, B. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.08.012 · Cited by 502
Muntner, P., He, J., Astor, B. C., Folsom, A. R., & Coresh, J. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004080656 · Cited by 493
Prostaglandin E2-induced inflammation: Relevance of prostaglandin E receptors
Kawahara, K., Hohjoh, H., Inazumi, T., Tsuchiya, S., & Sugimoto, Y. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.07.008 · Cited by 488
Primary and Secondary Prevention of Cardiovascular Disease
Vandvik, P. O., Lincoff, A. M., Gore, J. M., Gutterman, D. D., Sonnenberg, F. A., Alonso-Coello, P., Akl, E. A., Lansberg, M. G., Guyatt, G. H., & Spencer, F. A. (2012) · Chest · doi:10.1378/chest.11-2306 · Cited by 476
Wu, S., Moomaw, C. R., Tomer, K. B., Falck, J. R., & Zeldin, D. C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.7.3460 · Cited by 473
Rituximab-Induced Depletion of Anti-PLA2R Autoantibodies Predicts Response in Membranous Nephropathy
Beck, L. H., Fervenza, F. C., Beck, D. M., Bonegio, R. G. B., Malik, F. A., Erickson, S. B., Cosio, F. G., Cattran, D. C., & Salant, D. J. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010111125 · Cited by 471
Soluble Epoxide Hydrolase Regulates Hydrolysis of Vasoactive Epoxyeicosatrienoic Acids
Yu, Z., Xu, F., Huse, L. M., Morisseau, C., Draper, A. J., Newman, J. W., Parker, C., Graham, L., Engler, M. M., Hammock, B. D., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.11.992 · Cited by 467
Radhakrishnan, J., & Cattran, D. C. (2012) · Kidney International · doi:10.1038/ki.2012.280 · Cited by 417
Dunn, M. J., & Hood, V. L. (1977) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1977.233.3.f169 · Cited by 399
Pharmacology and therapeutics of omega-3 polyunsaturated fatty acids in chronic inflammatory disease
Yates, C. M., Calder, P. C., & Ed Rainger, G. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.10.010 · Cited by 395
Tögel, F., Isaac, J., Hu, Z., Weiss, K., & Westenfelder, C. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00275.x · Cited by 373
Sperling, R. I., Benincaso, A. I., Knoell, C. T., Larkin, J. K., Austen, K. F., & Robinson, D. R. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116245 · Cited by 349
Zhang, J., Ding, E. L., & Song, Y. (2006) · JAMA · doi:10.1001/jama.296.13.jrv60015 · Cited by 332
Powell, W. S., & Rokach, J. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.10.008 · Cited by 324
Ungprasert, P., Cheungpasitporn, W., Crowson, C. S., & Matteson, E. L. (2015) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2015.03.008 · Cited by 322 · cited 8×
“Thus, the relationship between 20-HETE and AKI may be further clarified.”
BackgroundInfluentialAntagonism of the prostaglandin D2 receptors DP1 and CRTH2 as an approach to treat allergic diseases
Pettipher, R., Hansel, T. T., & Armer, R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2266 · Cited by 317
Serhan, C. N., & Sheppard, K. A. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114503 · Cited by 313
Fujino, H., Xu, W., & Regan, J. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212665200 · Cited by 305
Lasker, J. M., Chen, W. B., Wolf, I., Bloswick, B. P., Wilson, P. D., & Powell, P. K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.6.4118 · Cited by 305
COX-1, COX-2, and COX-3 and the future treatment of chronic inflammatory disease
Willoughby, D. A., Moore, A. R., & Colville-Nash, P. R. (2000) · The Lancet · doi:10.1016/s0140-6736(99)12031-2 · Cited by 298
Mechanisms of Podocyte Injury in Diabetes
Eid, A. A., Gorin, Y., Fagg, B. M., Maalouf, R., Barnes, J. L., Block, K., & Abboud, H. E. (2009) · Diabetes · doi:10.2337/db08-1536 · Cited by 293
Enzyme with dual lipoxygenase activities catalyzes leukotriene A4 synthesis from arachidonic acid.
Shimizu, T., Rådmark, O., & Samuelsson, B. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.3.689 · Cited by 290
A Potential Role for Mechanical Forces in the Detachment of Podocytes and the Progression of CKD
Kriz, W., & Lemley, K. V. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014030278 · Cited by 286
Prostaglandin E receptors and the kidney
Breyer, M. D., & Breyer, R. M. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.279.1.f12 · Cited by 274
Goetzl, E. J., An, S., & Smith, W. L. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.11.7649404 · Cited by 271
Haas, M., Spargo, B. H., Wit, E.-J. C., & Meehan, S. M. (2000) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(00)70196-x · Cited by 269
The Prostanoid EP4 Receptor and Its Signaling Pathway
Yokoyama, U., Iwatsubo, K., Umemura, M., Fujita, T., & Ishikawa, Y. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.007195 · Cited by 264
Henoch–Schönlein purpura nephritis in children
Davin, J.-C., & Coppo, R. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.126 · Cited by 257
Management of Dyslipidemia in NIDDM
Garg, A., & Grundy, S. M. (1990) · Diabetes Care · doi:10.2337/diacare.13.2.153 · Cited by 254
Rajakariar, R., Hilliard, M., Lawrence, T., Trivedi, S., Colville-Nash, P., Bellingan, G., Fitzgerald, D., Yaqoob, M. M., & Gilroy, D. W. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707394104 · Cited by 253
COX-2-derived endocannabinoid metabolites as novel inflammatory mediators
Alhouayek, M., & Muccioli, G. G. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.03.001 · Cited by 252
Airway Lipoxin A 4 Generation and Lipoxin A 4 Receptor Expression Are Decreased in Severe Asthma
Planagumà, A., Kazani, S., Marigowda, G., Haworth, O., Mariani, T. J., Israel, E., Bleecker, E. R., Curran-Everett, D., Erzurum, S. C., Calhoun, W. J., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200801-061oc · Cited by 247
Clinical Importance of Hepatic Cytochrome P450 in Drug Metabolism
Spatzenegger, M., & Jaeger, W. (1995) · Drug Metabolism Reviews · doi:10.3109/03602539508998329 · Cited by 245
Devi, S., Wang, Y., Chew, W. K., Lima, R., A-González, N., Mattar, C. N. Z., Chong, S. Z., Schlitzer, A., Bakocevic, N., Chew, S., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130056 · Cited by 243
Fruchart, J.-C. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.03.008 · Cited by 233
Shen, H. C., & Hammock, B. D. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201468j · Cited by 229
Lipoxin A4 Attenuates Obesity-Induced Adipose Inflammation and Associated Liver and Kidney Disease
Börgeson, E., Johnson, A. M. F., Lee, Y. S., Till, A., Syed, G. H., Ali-Shah, S. T., Guiry, P. J., Dalli, J., Colas, R. A., Serhan, C. N., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.05.003 · Cited by 221
Postischemic renal injury is mediated by neutrophils and leukotrienes
Klausner, J. M., Paterson, I. S., Goldman, G., Kobzik, L., Rodzen, C., Lawrence, R., Valeri, C. R., Shepro, D., & Hechtman, H. B. (1989) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1989.256.5.f794 · Cited by 209
Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis
Berger, J. S., Brown, D. L., & Becker, R. C. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.10.002 · Cited by 203
LEUKOTRIENE B4, AN INFLAMMATORY MEDIATOR IN GOUT
Rae, S. A., Davidson, E. M., & Smith, M. J. H. (1982) · The Lancet · doi:10.1016/s0140-6736(82)92785-4 · Cited by 195
Prostaglandin Endoperoxide H Synthase-1
Thuresson, E. D., Lakkides, K. M., Rieke, C. J., Sun, Y., Wingerd, B. A., Micielli, R., Mulichak, A. M., Malkowski, M. G., Garavito, R. M., & Smith, W. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009377200 · Cited by 195
Fenofibrate, a PPARα agonist, has renoprotective effects in mice by enhancing renal lipolysis
Tanaka, Y., Kume, S., Araki, S.-I., Isshiki, K., Chin-Kanasaki, M., Sakaguchi, M., Sugimoto, T., Koya, D., Haneda, M., Kashiwagi, A., et al. (2011) · Kidney International · doi:10.1038/ki.2010.530 · Cited by 190
20-HETE and the kidney: resolution of old problems and new beginnings
McGiff, J. C., & Quilley, J. (1999) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1999.277.3.r607 · Cited by 186
Naraba, H., Murakami, M., Matsumoto, H., Shimbara, S., Ueno, A., Kudo, I., & Oh-ishi, S. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.6.2974 · Cited by 178
Jansen, M. P. B., Emal, D., Teske, G. J. D., Dessing, M. C., Florquin, S., & Roelofs, J. J. T. H. (2017) · Kidney International · doi:10.1016/j.kint.2016.08.006 · Cited by 178
Zeldin, D. C., Dubois, R. N., Falck, J. R., & Capdevila, J. H. (1995) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1995.1438 · Cited by 177
The enzymology of prostaglandin endoperoxide H synthases-1 and -2
Smith, W. L., & Song, I. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00025-4 · Cited by 173
20-Hydroxyeicosatetraeonic Acid: A New Target for the Treatment of Hypertension
Williams, J. M., Murphy, S., Burke, M., & Roman, R. J. (2010) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181f04b1c · Cited by 169
The Evolving Understanding of the Contribution of Lipid Metabolism to Diabetic Kidney Disease
Stadler, K., Goldberg, I. J., & Susztak, K. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0611-8 · Cited by 165
Unresolved Issues in the Role of Cyclooxygenase-2 in Normal Physiologic Processes and Disease
Lipsky, P. E., Brooks, P., Crofford, L. J., DuBois, R., Graham, D., Simon, L. S., van de Putte, L. B. A., & Abramson, S. B. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.7.913 · Cited by 164
Forget, P., Machiels, J.-P., Coulie, P. G., Berliere, M., Poncelet, A. J., Tombal, B., Stainier, A., Legrand, C., Canon, J.-L., Kremer, Y., et al. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-013-3136-x · Cited by 161
Powell, W. S., Gravelle, F., & Gravel, S. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41766-8 · Cited by 158
New aspects of the role of hydroxyeicosatetraenoic acids in cell growth and cancer development
Moreno, J. J. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.07.033 · Cited by 158
The Effects of Lipoxin A 4 on Airway Responses in Asthmatic Subjects
Christie, P. E., Spur, B. W., & Lee, T. H. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/145.6.1281 · Cited by 158
Acute Interstitial Nephritis: A Clinical and Morphological Study in 27 Patients
Buysen, J. G. M., Houthoff, H. J., Krediet, R. T., & Arisz, L. (1990) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/5.2.94 · Cited by 157
Nguyen, X., Wang, M.-H., Reddy, K. M., Falck, J. R., & Schwartzman, M. L. (1999) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1999.276.6.r1691 · Cited by 157
Bauer, J., Ripperger, A., Frantz, S., Ergün, S., Schwedhelm, E., & Benndorf, R. A. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12677 · Cited by 154
Interaction Between P450 Eicosanoids and Nitric Oxide in the Control of Arterial Tone in Mice
Hercule, H. C., Schunck, W., Groß, V., Seringer, J., Leung, F. P., Weldon, S. M., Gonçalves, A. C. D. C., Huang, Y., Luft, F. C., & Gollasch, M. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.171298 · Cited by 154
Perioperative Aspirin and Clonidine and Risk of Acute Kidney Injury
Garg, A. X., Kurz, A. M., Sessler, D. I., Cuerden, M. S., Robinson, A., Mrkobrada, M., Parikh, C. R., Mizera, R., Jones, P. M., Tiboni, M. E., et al. (2014) · JAMA · doi:10.1001/jama.2014.15284 · Cited by 152
Munger, K. A., Montero, A., Fukunaga, M., Uda, S., Yura, T., Imai, E., Kaneda, Y., Valdivielso, J. M., & Badr, K. F. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13375 · Cited by 148
Angiotensin II releases 20-HETE from rat renal microvessels
Croft, K. D., McGiff, J. C., Sánchez-Mendoza, A., & Carroll, M. A. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.279.3.f544 · Cited by 146
Lipoxin recognition sites. Specific binding of labeled lipoxin A4 with human neutrophils.
Fiore, S., Ryeom, S. W., Weller, P. F., & Serhan, C. N. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41982-5 · Cited by 139
Increased platelet sensitivity to ADP in mice lacking platelet-type 12-lipoxygenase
Johnson, E. N., Brass, L. F., & Funk, C. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.3100 · Cited by 139
Working Towards an Appropriate Use of Ibuprofen in Children: An Evidence-Based Appraisal
de Martino, M., Chiarugi, A., Boner, A. L., Montini, G., & Angelis, G. L. D. (2017) · Drugs · doi:10.1007/s40265-017-0751-z · Cited by 139
Overmeire, B. V., Allegaert, K., Casaer, A., Debauche, C., Decaluwe, W., Jespers, A., Weyler, J., Harrewijn, I., & Langhendries, J. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17477-1 · Cited by 138
Manhiani, M. M., Quigley, J. E., Knight, S. F., Tasoobshirazi, S., Moore, T., Brands, M. W., Hammock, B. D., & Imig, J. D. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00098.2009 · Cited by 137
Bleomycin-Induced E Prostanoid Receptor Changes Alter Fibroblast Responses to Prostaglandin E2
Moore, B. B., Ballinger, M. N., White, E. S., Green, M. E., Herrygers, A. B., Wilke, C. A., Toews, G. B., & Peters-Golden, M. L. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.9.5644 · Cited by 135
Cytochrome P450, the arachidonic acid cascade, and hypertension: new vistas for an old enzyme system
Makita, K., Falck, J. R., & Capdevila, J. H. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.13.8940291 · Cited by 131
Cyclooxygenase-3: axiom, dogma, anomaly, enigma or splice error?--Not as easy as 1, 2, 3.
Davies, N. M., Good, R. L., Roupe, K., & Yáñez, J. A. (2004) · PubMed · Cited by 128
The CYP P450 Arachidonic Acid Monooxygenases: From Cell Signaling to Blood Pressure Regulation
Capdevila, J. H., & Falck, J. R. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5167 · Cited by 127
Prostaglandin E2 Suppresses NK Activity In Vivo and Promotes Postoperative Tumor Metastasis in Rats
Yakar, I., Melamed, R., Shakhar, G., Shakhar, K., Rosenne, E., Abudarham, N., Page, G. G., & Ben‐Eliyahu, S. (2003) · Annals of Surgical Oncology · doi:10.1245/aso.2003.08.017 · Cited by 124
Clofibrate prevents the development of hypertension in Dahl salt-sensitive rats.
Roman, R. J., Ma, Y., Frohlich, B. H., & Markham, B. E. (1993) · Hypertension · doi:10.1161/01.hyp.21.6.985 · Cited by 121
Role of prostaglandins and leukotrienes in volume regulation by Ehrlich ascites tumor cells
Lambert, I. H., Hoffmann, E. K., & Christensen, P. (1987) · The Journal of Membrane Biology · doi:10.1007/bf01871187 · Cited by 121
Lipoxin A 4 and benzo‐lipoxin A 4 attenuate experimental renal fibrosis
Börgeson, E., Docherty, N. G., Murphy, M., Rodgers, K., Ryan, A., O’Sullivan, T. P., Guiry, P. J., Goldschmeding, R., Higgins, D. F., & Godson, C. (2011) · The FASEB Journal · doi:10.1096/fj.11-185017 · Cited by 121
Ekambaram, P., Lambiv, W. L., Cazzolli, R., Ashton, A. W., & Honn, K. V. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9297-9 · Cited by 118
Lipoxin A4 Antagonizes the Mitogenic Effects of Leukotriene D4 in Human Renal Mesangial Cells
McMahon, B. A., Stenson, C., McPhillips, F., Fanning, A., Brady, H. R., & Godson, C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001015200 · Cited by 117
Altered renal P-450 metabolism of arachidonic acid in Dahl salt-sensitive rats
Ma, Y., Schwartzman, M. L., & Roman, R. J. (1994) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1994.267.2.r579 · Cited by 113
Cloning and Expression of Murine CYP2Cs and Their Ability to Metabolize Arachidonic Acid
Luo, G., Zeldin, D. C., Blaisdell, J. A., Hodgson, E., & Goldstein, J. A. (1998) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1998.0806 · Cited by 111
Cellular components that functionally interact with signaling phospholipase A2s
Murakami, M., Nakatani, Y., Kuwata, H., & Kudo, I. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00118-9 · Cited by 107
Snider, N. T., Kornilov, A. M., Kent, U. M., & Hollenberg, P. F. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.119321 · Cited by 103
Edenius, C., Haeggström, J. Z., & Lindgren, J. Å. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)80320-6 · Cited by 102
Coulon, L., Calzada, C., Moulin, P., Véricel, E., & Lagarde, M. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(03)00386-1 · Cited by 102
Ramachandran, R., Hn, H. K., Kumar, V., Nada, R., Yadav, A. K., Goyal, A. K., Kumar, V., Rathi, M., Jha, V., Gupta, K. L., et al. (2015) · Nephrology · doi:10.1111/nep.12569 · Cited by 102
Differential localization of prostaglandin E receptor subtypes in human kidney
Breyer, M. D., Davis, L., Jacobson, H. R., & BREYER, R. M. (1996) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1996.270.5.f912 · Cited by 102
Muller, D., Theuer, J., Shagdarsuren, E., Kaergel, E., Honeck, H., Park, J.-K., Marković, M., Barbosa-Sicard, E., Dechend, R., Wellner, M., et al. (2004) · American Journal of Pathology · doi:10.1016/s0002-9440(10)63142-2 · Cited by 101
Porro, B., Songia, P., Squellerio, I., Tremoli, E., & Cavalca, V. (2014) · Journal of Chromatography B · doi:10.1016/j.jchromb.2014.03.015 · Cited by 100
Pathophysiologic Features and Prevention of Human and Experimental Acute Tubular Necrosis
Lameire, N. H., & Vanholder, R. C. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v12suppl_1s20 · Cited by 100
Lipoxins: Potential anti-inflammatory, proresolution, and antifibrotic mediators in renal disease
Kieran, N. E., MADERNA, P., & Godson, C. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00487.x · Cited by 97
Epoxyeicosatrienoic Acid Pathway in Human Health and Diseases
Bellien, J., & Joannidés, R. (2013) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318273b007 · Cited by 92
Egr-1 deficiency protects from renal inflammation and fibrosis
Ho, L., Sung, J., Shen, Y.-T., Jheng, H., Chen, S., Tsai, P.-J., & Tsai, Y.-S. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-016-1403-6 · Cited by 92
Gai, Z., Visentin, M., Gui, T., Zhao, L., Thasler, W. E., Häusler, S., Hartling, I., Cremonesi, A., Hiller, C., & Kullak-Ublick, G. A. (2018) · Molecular Pharmacology · doi:10.1124/mol.117.111047 · Cited by 91
Self-citationGemfibrozil Alone and in Combination With Lovastatin for Treatment of Hypertriglyceridemia in NIDDM
Garg, A., & Grundy, S. M. (1989) · Diabetes · doi:10.2337/diab.38.3.364 · Cited by 85
Inhibition of soluble epoxide hydrolase prevents renal interstitial fibrosis and inflammation
Kim, J., Imig, J. D., Yang, J., Hammock, B. D., & Padanilam, B. J. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00256.2014 · Cited by 84
Noiri, E., Yokomizo, T., Nakao, A., Izumi, T., Fujita, T., Kimura, S., & Shimizu, T. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.823 · Cited by 83
Carroll, M. A., Doumad, A. B., Li, J., Cheng, M. K., Falck, J. R., & McGiff, J. C. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00231.2005 · Cited by 83
Novel orally active epoxyeicosatrienoic acid (EET) analogs attenuate cisplatin nephrotoxicity
Khan, A. H., Liu, J., Kumar, G., Skapek, S. X., Falck, J. R., & Imig, J. D. (2013) · The FASEB Journal · doi:10.1096/fj.12-218040 · Cited by 82
Cyclooxygenase-derived proangiogenic metabolites of epoxyeicosatrienoic acids
Rand, A. A., Barnych, B. B., Morisseau, C. H. P., Čajka, T., Lee, K. S. S., Panigrahy, D., & Hammock, B. D. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1616893114 · Cited by 79
Mohamed, R., Jayakumar, C., Ranganathan, P. V., Ganapathy, V., & Ramesh, G. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.08.014 · Cited by 77
Lipoxins Regulate the Early Growth Response–1 Network and Reverse Diabetic Kidney Disease
Brennan, E. P., Mohan, M., McClelland, A., Tikellis, C., Ziemann, M., Kaspi, A., Gray, S. P., Pickering, R. J., Tan, S. M., Shah, S. T. A., et al. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017101112 · Cited by 76
Nakagawa, N., Yuhki, K., Kawabe, J.-I., Fujino, T., Takahata, O., Kabara, M., Abe, K., Kojima, F., Kashiwagi, H., Hasebe, N., et al. (2012) · Kidney International · doi:10.1038/ki.2012.115 · Cited by 75
Okamura, D. M., López-Guisa, J. M., Koelsch, K., Collins, S., & Eddy, A. A. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00063.2007 · Cited by 74
Williams, J. M., Sarkis, A., López, B., Ryan, R. P., Flasch, A. K., & Roman, R. J. (2007) · Hypertension · doi:10.1161/01.hyp.0000255753.89363.47 · Cited by 73
CHANG, J. Y., Blazek, E. M., Kreft, A. F., et al. (1985) · Biochemical Pharmacology · doi:10.1016/0006-2952(85)90701-4 · Cited by 72
Lipman, G. S., Shea, K., Christensen, M. L., Phillips, C. T., Burns, P., Higbee, R., Koskenoja, V., Eifling, K. P., & Krabak, B. J. (2017) · Emergency Medicine Journal · doi:10.1136/emermed-2016-206353 · Cited by 71
Moreno, C. (2001) · American Journal of Hypertension · doi:10.1016/s0895-7061(01)02075-1 · Cited by 70
Inside epoxyeicosatrienoic acids and cardiovascular disease
Tacconelli, S., & Patrignani, P. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00239 · Cited by 70
Rodgers, K., McMahon, B. A., Mitchell, D., Sadlier, D. M., & Godson, C. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62043-3 · Cited by 69
Cheng, X. Y., He, S., Yuan, J., Miao, S., Gao, H., Zhang, J., Yang, L., Peng, W., & Wu, P. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.01.026 · Cited by 69
Kotnik, P., Nielsen, J., Kwon, T., Kržišnik, C., Frøkiær, J., & Nielsen, S. S. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00114.2004 · Cited by 67
Transforming Growth Factor-β, 20-HETE Interaction, and Glomerular Injury in Dahl Salt-Sensitive Rats
Dahly-Vernon, A. J., Sharma, M., McCarthy, E. T., Savin, V. J., Ledbetter, S. R., & Roman, R. J. (2005) · Hypertension · doi:10.1161/01.hyp.0000153791.89776.43 · Cited by 67
Hecker, M., Haurand, M., Ullrich, V., Diczfalusy, U., & Hammarström, S. (1987) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(87)90088-9 · Cited by 65
Colebatch, A. N., Marks, J. L., van der Heijde, D. M. F. M., & Edwards, C. J. (2012) · Journal of Rheumatology Supplement · doi:10.3899/jrheum.120345 · Cited by 64
Wang, D., Borrego-Conde, L. J., Falck, J. R., Sharma, K. K., Wilcox, C. S., & Umans, J. G. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00036.x · Cited by 63
Self-citationMembranous Nephropathy and Nonsteroidal Anti-inflammatory Agents
Nawaz, F., Larsen, C. P., & Troxell, M. L. (2013) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.03.045 · Cited by 63
Wu, S., Liao, P., Yin, P., Zhang, Y., & Dong, L. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080671 · Cited by 62
Cheng, M. K., Doumad, A. B., Jiang, H., et al. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705640 · Cited by 62
A Maladaptive Role for EP4 Receptors in Podocytes
Stitt-Cavanagh, E. M., Faour, W. H., Takami, K., Carter, A., Vanderhyden, B. C., Guan, Y., Schneider, A., Breyer, M. D., & Kennedy, C. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009121234 · Cited by 62
Differential regulation of renal prostaglandin receptor mRNAs by dietary salt intake in the rat
Jensen, B. L., Mann, B., Skøtt, O., & Kurtz, A. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00564.x · Cited by 61
Mastyugin, V., Aversa, E., Bonazzi, A., Vafaes, C., Mieyal, P. A., & Schwartzman, M. L. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38312-0 · Cited by 61
COX‐3—a virtual pain target in humans?
Schwab, J. M., Beiter, T., Linder, J. U., Laufer, S., Schulz, J. E., Meyermann, R., & Schluesener, H. J. (2003) · The FASEB Journal · doi:10.1096/fj.03-0595lte · Cited by 59
Landgraf, S. S., Silva, L. S., Peruchetti, D. B., Sirtoli, G. M., Moraes-Santos, F., Portella, V. G., Silva‐Filho, J. L., Pinheiro, C. S., de Abreu, T. P., Takiya, C. M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107549 · Cited by 58
PGE2 induces COX-2 expression in podocytes via the EP4 receptor through a PKA-independent mechanism
Faour, W. H., Gomi, K., & Kennedy, C. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.08.007 · Cited by 58
20-HETE-mediated cytotoxicity and apoptosis in ischemic kidney epithelial cells
Nilakantan, V., Maenpaa, C., Jia, G., Roman, R. J., & Park, F. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00387.2007 · Cited by 57
PGD2-CRTH2 Pathway Promotes Tubulointerstitial Fibrosis
Ito, H., Yan, X., Nagata, N., Aritake, K., Katsumata, Y., Matsuhashi, T., Nakamura, M., Hirai, H., Urade, Y., Asano, K., et al. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012020126 · Cited by 57
Deng, B.-Q., Luo, Y., Kang, X., Li, C.-B., Morisseau, C. H. P., Yang, J., Lee, K. S. S., Huang, J., Hu, D.-Y., Wu, M.-Y., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1705615114 · Cited by 57
Egr-1 Mediates Chronic Hypoxia-Induced Renal Interstitial Fibrosis via the PKC/ERK Pathway
Sun, S., Ning, X., Zhai, Y., Du, R., Lu, Y., He, L., Li, R., Wu, W., Sun, W., & Wang, H. (2014) · American Journal of Nephrology · doi:10.1159/000362249 · Cited by 56
COX-2, the dominant source of prostacyclin
Ricciotti, E., Yu, Y., Großer, T., & FitzGerald, G. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219073110 · Cited by 53
Alsaad, A. M. S., Zordoky, B. N. M., Tse, M. M. Y., & El‐Kadi, A. O. S. (2013) · Drug Metabolism Reviews · doi:10.3109/03602532.2012.754460 · Cited by 53
Chronic kidney disease: targeting prostaglandin E2receptors
Nasrallah, R., Hassouneh, R., & Hébert, R. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00224.2014 · Cited by 52
Collins, X. H., Harmon, S. D., Kaduce, T. L., Berst, K. B., Fang, X., Moore, S. A., Raju, T. V., Falck, J. R., Weintraub, N. L., Duester, G., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504055200 · Cited by 52
Bahia, M. S., Katare, Y. K., Silakari, O., Vyas, B., & Silakari, P. (2014) · Medicinal Research Reviews · doi:10.1002/med.21306 · Cited by 51
Gounaris, E. G., Heiferman, M. J., Heiferman, J. R., Shrivastav, M., Vitello, D. J., Blatner, N. R., Knab, L. M., Phillips, J. D., Cheon, E. C., Grippo, P. J., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121402 · Cited by 48
Gas6, warfarin, and kidney diseases
Yanagita, M. (2004) · Clinical and Experimental Nephrology · doi:10.1007/s10157-004-0305-z · Cited by 47
The universe of arachidonic acid metabolites in inflammatory bowel disease
Stenson, W. F. (2014) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000075 · Cited by 43
Transfer of the CYP4A region of chromosome 5 from Lewis to Dahl S rats attenuates renal injury
Williams, J. M., Sarkis, A., Hoagland, K. M., Fredrich, K. M., Ryan, R. P., Moreno, C., López, B., Lazar, J., Fenoy, F. J., Sharma, M., et al. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90525.2008 · Cited by 41
Chauhan, G., Roy, K., Kumar, G., Kumari, P., Alam, S., Kishore, K., Panjwani, U., & Ray, K. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.11.026 · Cited by 41
Kopp, B. T., Thompson, R., Kim, J. D., Konstan, R., Díaz, A., Smith, B., Shrestha, C. L., Rogers, L. K., Hayes, D., Tumin, D., et al. (2019) · Thorax · doi:10.1136/thoraxjnl-2018-211845 · Cited by 41
Polyunsaturated fatty acids and signalling via phospholipase C-β and A2 in myocardium
de Jonge, H. W., Dekkers, D. H. W., & Lamers, J. M. J. (1996) · Molecular and Cellular Biochemistry · doi:10.1007/bf00227899 · Cited by 40
Faulkner, J. (2015) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000555 · Cited by 40
Hassouneh, R., Nasrallah, R., Zimpelmann, J., Gutsol, A. A., Eckert, D., Ghossein, J., Burns, K. D., & Hébert, R. (2016) · Diabetologia · doi:10.1007/s00125-016-3916-5 · Cited by 39
Somparn, P., Hirankarn, N., Leelahavanichkul, A., Khovidhunkit, W., Thongboonkerd, V., & Avihingsanon, Y. (2012) · Journal of Proteomics · doi:10.1016/j.jprot.2012.03.034 · Cited by 37
Sánchez, T., & Moreno, J. J. (2002) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00128.2001 · Cited by 37
Drug-induced tubulointerstitial nephritis: hypersensitivity and necroinflammatory pathways
Eddy, A. A. (2019) · Pediatric Nephrology · doi:10.1007/s00467-019-04207-9 · Cited by 36
Shahabi, P., Siest, G., & Visvikis‐Siest, S. (2013) · Drug Metabolism Reviews · doi:10.3109/03602532.2013.837916 · Cited by 35
Green, A. R., Freedman, C. J., Tena, J., Tourdot, B. E., Liu, B., Holinstat, M. A., & Holman, T. R. (2018) · Biochemistry · doi:10.1021/acs.biochem.8b00889 · Cited by 34
Peroxisome proliferator activating receptor-γ and the podocyte
Platt, C., & Coward, R. J. (2016) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfw320 · Cited by 33
Roche, C., Guerrot, D., Harouki, N., Duflot, T., Besnier, M., Rémy‐Jouet, I., Renet, S., Dumesnil, A., Lejeune, A., Morisseau, C. H. P., et al. (2015) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2015.04.011 · Cited by 29
Kwon, S., Wang, Y., Chen, J., Zhang, M.-Z., Harris, R. C., & Chen, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0113130 · Cited by 28
Elucidating the Role of Interleukin 1β and Prostaglandin E2 in Upper Airway Mucosal Wound Healing
Sandulache, V. C., Chafin, J. B., Li‐Korotky, H., Otteson, T. D., Dohar, J. E., & Hebda, P. A. (2007) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.133.4.365 · Cited by 28
Aspirin and Mortality from Coronary Bypass Surgery
Chesebro, J. H., Fuster, V., & Pugo, F. J. (2003) · New England Journal of Medicine · doi:10.1056/nejm200303133481114 · Cited by 26
Frölich, S., Olliges, A., Kern, N., Schreiber, Y., Narumiya, S., & Nüsing, R. M. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00418.2011 · Cited by 26
PTGER1 Deletion Attenuates Renal Injury in Diabetic Mouse Models
Thibodeau, J.-F., Nasrallah, R., Carter, A., He, Y., Touyz, R. M., Hébert, R., & Kennedy, C. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.08.022 · Cited by 23
Ubiquitous localization of leukotriene A4 hydrolase in the rat nephron
Nakao, A., Watanabe, T., Ohishi, N., Toda, A., Asano, K., Taniguchi, S., Nosaka, K., Noiri, E., Suzuki, T., Sakai, T., et al. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00257.x · Cited by 19
Siavash, M., & Amini, M. (2014) · Journal of Research in Pharmacy Practice · doi:10.4103/2279-042x.141075 · Cited by 18
2,3-Diarylxanthones as Potential Inhibitors of Arachidonic Acid Metabolic Pathways
Santos, C. M. M., Ribeiro, D., Silva, A. M. S., & Fernandes, E. G. R. (2017) · Inflammation · doi:10.1007/s10753-017-0540-6 · Cited by 18
Increased severity of renal impairment in nephritic mice lacking the EP1 receptor
Rahal, S. S., McVeigh, L. I., Zhang, Y., Guan, Y., Breyer, M. D., & Kennedy, C. (2006) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y06-029 · Cited by 17
Lu, Y., Zhou, Q., Zhong, F., Guo, S., Xu, H., Li, C., Wang, W., & Chen, N. (2013) · Nephron Experimental Nephrology · doi:10.1159/000353232 · Cited by 13
Kinetic investigation of human 5-lipoxygenase with arachidonic acid
Mittal, M., Kumar, R. B., Balagunaseelan, N., Hámberg, M., Jegerschöld, C., Rådmark, O., Haeggström, J. Z., & Rinaldo-Matthis, A. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.06.025 · Cited by 12
Effect of aging on renal cytochrome P450-dependent arachidonic acid metabolism in Dahl rats.
Omata, K., TSUTSUMI, E., Sheu, H.-L., Utsumi, Y., & Abe, K. (1993) · PubMed · Cited by 11
Martín-Navarro, J. A., Stoyanov, V. P., Gutiérrez-Sánchez, M. J., & Cezón, L. A. P. (2015) · Nefrología · doi:10.1016/j.nefro.2015.06.022 · Cited by 5
Cited by
Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets
Wang, B., Wu, L., Chen, J., Dong, L., Chen, C., Wen, Z., Hu, J., Fleming, I., & Wang, D. W. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00443-w · Cited by 1,414
Self-citationThe emerging role of ferroptosis in inflammation
Sun, Y., Chen, P., Zhai, B., Zhang, M., Xiang, Y., Fang, J., Xu, S., Gao, Y., Chen, X., Sui, X., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110108 · Cited by 739
GPX4 in cell death, autophagy, and disease
Xie, Y., Kang, R., Klionsky, D. J., & Tang, D. (2023) · Autophagy · doi:10.1080/15548627.2023.2218764 · Cited by 623
Wang, Y.-L., Lee, Y.-H., Hsu, Y.-H., Chiu, I.-J., Huang, C. C.-Y., Huang, C.-C., Chia, Z.-C., Lee, C.-P., Lin, Y.-F., & Chiu, H.-W. (2021) · Environmental Health Perspectives · doi:10.1289/ehp7612 · Cited by 383
Arachidonic acid metabolism in health and disease
Zhang, Y., Liu, Y., Sun, J., Zhang, W., Guo, Z., & Ma, Q. (2023) · MedComm · doi:10.1002/mco2.363 · Cited by 295
Metadata
- Authors
- Wang, T., Fu, X., Chen, Q., Patra, J. K., Wang, D., Wang, Z., & Gai, Z.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2019-07-27
- Volume
- 20
- Issue
- 15
- Pages
- 3683
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2965888264
- Cited by
- 430
- References
- 186
- FWCI
- 11.41
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.